Attorney General Steve Rowe announced today that a settlement agent is cutting checks totaling more than $82,000 to 264 Maine heart patients who purchased the drug Cardizem CD at a price that was inflated by corporate practices that violated the antitrust laws.

Attorney General Steven Rowe announced that a York County jury yesterday convicted registered nurse Jill Cote, 32, of Waterboro, of acquiring drugs by deception (class C). On July 28, 2003, while Jill Cote was working as a registered nurse at the York County Jail in Alfred, Cote diverted 60 Demerol pills by placing an order to the pharmacy for an inmate who was allergic to the medication. She was the last person in possession of the medications, which were never administered to the inmate or any other inmate at the jail.

Attorney General Steven Rowe today announced that he has issued a notice of intent to sue Trilegiant Corporation, Chase Bank USA, N.A., and Chase Manhattan Mortgage Corporation for violating the Maine Unfair Trade Practices Act in connection with their marketing of membership clubs to Maine residents. Maine law requires that the notices be sent at least ten days prior to filing suit seeking an injunction in court.

Just in time for the big Columbus Day Factory Clearance Mega Blowout sales at auto dealerships around Maine, new auto advertising rules will start to protect consumers from deceptive practices. Attorney General Steve Rowe announced today that regulations his office adopted this week will govern advertising layouts, vehicle pricing, the availability of advertised vehicles, and rebate offers. The rules will take effect on October 1, allowing dealers and ad agencies time to prepare for the change.

Attorney General Steve Rowe today expressed satisfaction that a federal appeals court in Washington, D.C., blocked some of the polluter-friendly loopholes the United States Environmental Protection Agency's (EPA's) 2002 New Source Review rulemaking. The court also rejected claims by industrial polluters that even the watered-down rules adopted by EPA were too strict.

Attorney General Steven Rowe announced today that his office has filed court papers under the Maine Civil Rights Act against Steven Wadleigh, 40, of Vinalhaven. The State alleges that, on April 20, 2005, Wadleigh approached a 33-year-old African American man while boarding the ferry between Rockland and Vinalhaven, and directed racial epithets at him. Rockland police responded and warned Wadleigh to refrain from harassing the victim.

Today at Baxter State Park Headquarters in Millinocket, long-time Baxter State Park Director Irvin "Buzz" Caverly announced his decision to retire. Caverly announced that he will retire on July 1 after more than 46 years of employment with the Park. Caverly has served as the Park's Director since 1981. Caverly made his announcement before a gathering of the Baxter State Park Authority and staff.

Attorney General Steven Rowe announced today that Susan Cole, 54, of Kennebunk, will serve five days in jail for stealing narcotics from Kennebunk Nursing Center, where she worked as a nurse from February through May, 2004. A York County Superior Court jury found Cole guilty in May of this year following a two day trial, and Superior Court Justice Arthur Brennan sentenced Cole to jail on Friday, June 17, 2005.

Attorney General Steven Rowe today warned Mainers that professional con artists are using the pretense of a Canadian lottery to bilk Mainers out of thousands of dollars, with a new twist: they send a cashiers check. "IGA Management Payment Systems," which claims to do business from Ottawa, is mailing letters to Maine residents announcing that they have won the "North American Prize Pool." Recipients of the letter are told that they have won over three hundred thousand dollars in cash.

Consumers who purchased the brand-name prescription medication Hytrin are eligible for refunds from a $30.7-million settlement agreement, Attorney General Steven Rowe announced today. The refunds to consumers and health plans in 18 states will be paid by two companies which, the complaint alleged, conspired to engage in anticompetitive conduct that delayed the availability of a more affordable generic version of the medication.